Yesterday, our #Boston team and MassGeneral Medicine advisor Dr. Keyes spoke about #lungcancer #screening at the Fathers United, Never Divided Men's Brunch!! Our team was moved by each of the inspirational speakers and honored to spread the word about #earlydetection ❤️

Our ALCSI team just published a study in Journal of Clinical Oncology showing that using pack-years to determine #lungcancerscreening eligibility has major limitations. Using a duration cutoff probably is better: ascopubs.org/doi/10.1200/JC…

‼️ Important work that should motivate rapid revision #lungcancer screening guidelines.

Reminder:
>50% of pts w/ #lungcancer wouldn’t have qualified for screening; this is enriched for women + racial minorities

>50% of pts w/ #lungcancer are already incurable (stage IV) at dx

.Alexandra Potter and Priyanka Senthil just published a study in The Annals of Thoracic Surgery showing that the 10-year OS of #NLST pts undergoing lobectomy for stage IA NSCLC was 58%. Nearly 1 in every 4 pts died from #lungcancer during the 10 years after lobectomy.
authors.elsevier.com/c/1io85ovKhFKh

The renal consult team really hates it when the ICU performs a kidney transplant before even trying lasix 200 + metolazone

Personalized cancer risk scores + tailored screening regimens are the future. #OliviaMunn is an early adopter + recently shared how this led to a dx of bilateral #breastcancer @ 43yo.

#Cancer can happen to anyone. We need to catch it early, when it’s curable. #earlydetection

Last week, our Boston team shared #lungcancer #screening resources at the American Red Cross Food Pantry. We were moved by the stories shared by many families affected by lung cancer and will be back soon to continue spreading the word about #earlydetection !!

🚨 News alert! The amazing Aurora, who was dx with EGFR lung cancer at the age of 28, is featured on NBC News and bc of her, lung cancer is on the front page of the website! Let’s read/share this article far & wide so LC gets the attention it needs! 😭
➡️ nbcnews.com/news/us-news/a…

I cannot overstate the importance of near-peer mentors. They're traveling the road just ahead of you and hold a wealth of knowledge! I'm lucky to have two great ones in thoracic colleagues Justin Becker and Alissa Cooper, MD. #TTLC24 MGH Thoracic Oncology

So grateful to be learning from these incredible oncologists and people. 🙏

A dynamic, engaging, and thoughtful discussion of ALK-independent resistance mechanisms by I.DagogoJackMD. She asks: is the first line actually the best setting for deploying combination therapies? 🔥 #TTLC24 IASLC MGH Women in Oncology MGH Thoracic Oncology

A nuanced + thoughtful discussion by JessicaJLinMD re: what can/can’t be generalized from adjuvant TKI trials—can ADAURA/ALINA be extended to other oncogene-driven NSCLC? Conceptually, yes. But we need more work to delineate specific tox profiles to best counsel our pts. #TTLC24

Beautiful talk by superstar first year fellow Sarah Waliany, MD, MS sharing findings from a retrospective study of carbo/pem + ALK TKI vs carbo/pem alone after progression of ALK TKI monotherapy, which results in clinically meaningful CNS control. 🔥🙌 #TTLC24 IASLC MGH Women in Oncology MGH Thoracic Oncology

Provocative talk by Dr. Jia Luo, MD about NUT carcinoma—it’s more common than we think!

☝️Take homes: you need RNA NGS, IHC, or FISH for proper diagnosis. Think of testing in young patients with poorly differentiated squamous cell #lungcancer . IASLC Dana-Farber #TTLC24

🔥🙏 Grateful for this powerful Women in Thoracic Oncology session, and grateful for the all of the important women mentors in my life. IASLC #TTLC24

Really enjoyed the new “tobacco moments” at #TTLC24 , this one given by Nasser Hanna As lung cancer providers, we can (and must) end stigma and blame, but ALSO work to promote smoking cessation and policies that end tobacco. Both serve lung cancer patients. Thank you IASLC

Clear and compelling talk by rising star Dr. Alissa Cooper, MD about the future of ADCs in #lungcancer —novel ADC constructs, and combining ADCs with immunotherapy. #TTLC24 IASLC MGH Women in Oncology Memorial Sloan Kettering Cancer Center